Paternal acceptance of the new RSV-prophylaxis for newborns at the LMU clinic

Paternal acceptance of the new RSV-prophylaxis for newborns at the LMU clinic - the RSV-new study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00035342

Enrollment

900

Registered

2025-01-15

Start date

2024-11-25

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Z25.8

Interventions

Group 1: Parents of newborns in the maternity ward or monitoring unit at the perinatal center in Großhadern and city center

Eligibility

Sex/Gender

All

Age

No minimum to 10 Days

Inclusion criteria

Inclusion criteria: children =35+0 weeks of gestation and their parents

Exclusion criteria

Exclusion criteria: Premature babies <35+0 weeks of gestation and their parents

Design outcomes

Primary

Measure	Time frame
percentage of newborns that receive the RSV-prophylaxis with their U2 examination	—

Secondary

Measure	Time frame
percentage of mothers who gave birth and received the RSV_prophylaxis during pregnancy under all mothers who gave birth Parental satisfaction with information	—

Countries

Germany

Contacts

Public ContactAndreas Flemmer

LMU Klinikum München, Dr. v. Haunersches Kinderspital & Perinatalzentrum, Neonatologie, Campus Großhadern u. Innenstadt

andreas.flemmer@med.uni-muenchen.de+49(0)89440072800/7280

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026